MYD88 and diffuse large B-cell lymphoma: Therefore, this study intends to investigate the clinical characteristics, genetic alteration, and survival of DLBCL patients between MYD88L265P and MYD88other variants through retrospective analysis of 132 patients with MYD88 variations in a cohort of 475 DLBCL patients from the Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CHCAMS), and Suzhou Municipal Hospital, hoping to better detail the clinical and genetic background of DLBCL patients with MYD88L265P and MYD88other.